News Aquaporin A/S

Equities

AQP

DK0061555109

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:32 2024-04-26 am EDT			5-day change	1st Jan Change
14.35 ^DKK	-2.05%		-4.01%	-68.80%

Apr. 05	Transcript : Aquaporin A/S, 2023 Earnings Call, Apr 05, 2024
Apr. 05	Aquaporin A/S Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Major shareholder announcement	Apr. 25	AQ
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Aquaporin's shares	Apr. 25	AQ
Aquaporin raises DKK 172 million	Apr. 25	AQ
Notice convening the annual general meeting 2024	Apr. 05	AQ
Transcript : Aquaporin A/S, 2023 Earnings Call, Apr 05, 2024	Apr. 05
Aquaporin publishes prospectus and initiates rights issue	Apr. 05	AQ
Aquaporin A/S Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 05	CI
Aquaporin announces full-year 2023 results, with year-on-year revenue growth of 95%	Apr. 05	AQ
Aquaporin A/S Provides Earnings Guidance for the Year 2024	Apr. 05	CI
London Stocks Retreat Ahead of Final UK GDP Data for Q4 2023	Mar. 25	MT
AstraZeneca Says Ultomiris Gets US FDA Approval to Treat Neuromyelitis Optica Spectrum Disorder	Mar. 25	MT
AstraZeneca Bags US FDA Clearance for Rare Autoimmune Disease Treatment Ultomiris	Mar. 25	MT
AstraZeneca Receives US Approval for Neuromyelitis Optica Spectrum Disorder Treatment	Mar. 25	MT
Business transacted at the extraordinary general meeting of Aquaporin A/S	Mar. 22	AQ
Notice to convene Extraordinary General Meeting	Feb. 29	AQ
Update on rights issue process, extraordinary general meeting, and financial calendar	Feb. 29	AQ
Aquaporin announces changes in Executive Management Team	Feb. 02	AQ
Aquaporin Announces Changes in Executive Management Team	Feb. 02	CI
Preliminary unaudited key financial numbers for 2023 in line with guidance and intention to strengthen capital structure	Jan. 29	AQ
Aquaporin A/S Provides Earnings Guidance for the Financial Year 2024	Jan. 29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Aquaporin A/S

Equities

AQP

DK0061555109

Summary

Filters